ArticleFrontiers in immunology2026

Real-world sinonasal outcomes in patients with primary diffuse chronic rhinosinusitis treated with mepolizumab across polyp phenotypes.

Nitish Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.